Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LG00034053 in Knee Osteoarthritis
NCT05237752Phase 2Completed
- Sponsor
- LG Chem
- Start
- Apr 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of LG00034053 in osteoarthritis (OA), sponsored by LG Chem. Started Apr 2022; status: completed.
02
Drugs
LG00034053
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05237752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05237752.